MDS-110 SELECT-MDS-1 Trial in Progress: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene/Azacitidine Versus Placebo/Azacitidine in Newly Diagnosed Adult Patients Selected for RARA-Positive Higher-Risk MDS

1. DeZern, A.
2. Fenaux, P.
3. Deeren, D.
4. Campelo, M.D.
5. Lübbert, M.
6. Krishnamurthy, P.
7. Nagy, Z.
8. Basak, G.
9. ová, A.J.
10. Geissler, K.
11. Ofran, Y.
12. Volkert, A.
13. Baker, K.
14. Chisholm, J.
15. Kang-Fortner, Q.
16. Roth, D.A.
17. Kelly, M.
18. Marconi, G.